Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Background Precise risk stratification-based treatment of solitary intrathyroidal papillary
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …

The classical mitogen-activated protein kinase (MAPK) signaling pathway, the Ras/Raf/MEK
(mitogen-activated protein kinase/ERK kinase)/ERK protein kinase cascade, is a conserved …

The aim of the present study was to examine the rate of BRAF mutation and the expression
profiles of CK19, galectin‑3, CD56, thyroid peroxidase (TPO) and Ki67 in papillary thyroid …

Background Prophylactic central lymph node dissection (PCLND) for adult patients with
papillary thyroid carcinoma (PTC) is still a matter of debate. Data on incidence, risk and …

Scholars are striving to apply molecular biology involving long non-coding RNA (lncRNA) in
the prognostication of papillary thyroid cancer (PTC). However, the clinical role of lncRNAs …

Simple Summary Age-adjusted thyroid cancer incidence is lower in the Hispanic population
than in the non-Hispanic White and Asian Pacific Islander populations. However, prior …

Background The primary goal of papillary thyroid cancer (PTC) management was to stratify
patients at pre-and post-surgical level to identify the small proportion of cases with …

The intracellular level of podoplanin (PDPN), a transmembrane protein of still unclear
function, is frequently altered in metastatic tumors. High expression of PDPN is frequently …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …